ABSTRACT:
Psoriasis is a chronic autoimmune condition that results in the rapid growth of skin cells, causing red, scaly patches. Despite the availability of several treatments, including topical corticosteroids and biologics, managing psoriasis remains challenging due to side effects, non-compliance, and limited long-term efficacy. Dithranol, a widely used treatment for psoriasis, has proven effective due to its anti-inflammatory and antiproliferative properties. However, its clinical use is hindered by poor solubility, skin irritation, and staining of both the skin and clothing.
This study aimed to develop a novel Dithranol-loaded ethosomal gel, which could enhance its solubility, stability, skin penetration, and therapeutic efficacy while minimizing irritation and side effects.
Ethosomes are lipid-based nanocarriers made from phospholipids, cholesterol, and alcohol, which can improve the skin penetration of drugs and provide controlled, sustained release.
Given these characteristics, ethosomes were chosen as the drug delivery system for this study to optimize the delivery of Dithranol and make it more effective for treating psoriasis. The study focused on developing a formulation that could not only improve drug absorption through the skin but also offer longer-lasting therapeutic effects.
Compared to traditional Dithranol creams, the ethosomal gel showed superior therapeutic effects with fewer side effects, particularly skin irritation and burning sensations.
Cite this article:
Pankaj Kumar, Satyam Namdev, Rimjhim Rajpoot, Dr. Kuldeep Kumar Savita.Formulation and Evaluation of Dithranol Ethosomes for Psoriasis. IJRPAS. 2025; 4(9): 42-53.DOI: https://doi.org/https://doi.org/10.71431/IJRPAS.2025.4905
1.
Davidovici BB, Sattar N, Jörg PC, Puig L,
Emery P, Barker JN, Van De Kerkhof P, Ståhle M, Nestle FO, Girolomoni G,
Krueger JG. Psoriasis and systemic inflammatory diseases: potential mechanistic
links between skin disease and co- morbid conditions. Journal
of Investigative Dermatology. 2010 Jul 1;130(7):1785- 96.
2. Vičić M, Kaštelan M, Brajac I, Sotošek V,
Massari LP. Current concepts of psoriasis immunopathogenesis. International
Journal of Molecular Sciences. 2021 Oct 26;22(21):11574.
3.
Kimball
AB, Jacobson C, Weiss S, Vreeland MG, Wu Y. The psychosocial burden of psoriasis. American journal of clinical dermatology.
2005 Dec;6:383-92.
4.
Zhang Y, Dong S, Ma Y, Mou Y. Burden of
psoriasis in young adults worldwide from the global burden of disease study
2019. Frontiers in Endocrinology. 2024 Feb 13;15:1308822.
5.
Gupta A, Bhalani S, Chopra A, Jabin F,
Gaur A, Kukreja I, Roy A, Brooks L, Sulzicki M, Verma V, Pandey S. EPH142
Epidemiological Disease Burden and Cost of Illness of Psoriasis in the US.
Value in Health. 2022 Jul 1;25(7):S460-1.
6.
Reynolds
KA, Pithadia DJ, Lee EB, Clarey D, Liao W, Wu JJ. Generalized pustular psoriasis: a review of the
pathophysiology, clinical manifestations, diagnosis, and treatment. Cutis. 2022
Aug 1;110(2 Suppl):19-25.
7.
Kammerau B, Zesch A, Schaefer H. Absolute
concentrations of dithranol and triacetyl-dithranol in the skin layers after local treatment: in vivo investigations with four different types
of pharmaceutical vehicles. Journal of Investigative Dermatology. 1975 Mar
1;64(3):145-9.
8.
Zhang H, Zhai Y, Wang J, Zhai G. New progress and prospects: The application of nanogel in drug delivery. Materials
Science and Engineering: C. 2016 Mar 1;60:560-8.
9.
Murphy EA, Majeti BK, Mukthavaram R, Acevedo LM, Barnes LA, Cheresh DA. Targeted nanogels: a versatile
platform for drug delivery to tumors. Molecular cancer therapeutics. 2011 Jun
1;10(6):972-82.
10.
Thabet Y, Elsabahy
M, Eissa NG. Methods for preparation of niosomes: A focus on thin-film hydration method.
Methods. 2022 Mar 1;199:9-15.
11.
Barupal AK, Gupta V, Ramteke S.
Preparation and characterization of ethosomes for topical delivery of
aceclofenac. Indian journal of pharmaceutical sciences. 2010 Sep;72(5):582.
12.
Jain A, Jain SK. In vitro release kinetics
model fitting of liposomes: An insight. Chemistry and physics of lipids. 2016
Dec 1;201:28-40.
13.
Agarwal R, Katare OP, Vyas SP. Preparation
and in vitro evaluation of liposomal/niosomal
delivery systems for antipsoriatic drug dithranol. International journal of pharmaceutics.
2001 Oct 9;228(1-2):43-52.
14.
Fathalla D, Youssef EM, Soliman GM.
Liposomal and ethosomal gels for the topical delivery of anthralin:
preparation, comparative evaluation and clinical assessment in psoriatic patients.
Pharmaceutics. 2020 May;12(5):446.